Security key
171077407
Niagen Bioscience, Inc. - Common Stock (NAGE)
CUSIP: 171077407
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 36,661,503
- Total 13F value
- $162,291,132
- Share change
- +4,044,358
- Put/Call ratio
- 452%
- SEC-reported price per share
- $4.41
- Number of holders
- 141
- Value change
- +$13,097,098
- Number of buys
- 72
- Number of sells
- 94
- Shares outstanding
- 80,031,269
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
141
Top holders
10
NAGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Niagen Bioscience, Inc. SEC filings
Niagen Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 171077407
Recent filing periods:
Ownership snapshot
Top reported holders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 4.1%
13D/G row: VANGUARD GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
4.1%
BlackRock, Inc.
5.1%
Tieton Capital Management, LLC
2.1%
ARROWSTREET CAPITAL, LIMITED PART...
2%
UBS Group AG
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
13F
The Vanguard Group · Company
|
4.1%
|
$20,902,127
3,286,498 shares
|
-$4,675,567 | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
5.1%
|
$25,921,508
4,075,709 shares
|
— | 31 Dec 2025 |
| Tieton Capital Management, LLC |
13F
Company
|
2.1%
|
$10,463,000
1,645,093 shares
|
— | 31 Dec 2025 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
Company
|
2%
|
$10,282,543
1,616,752 shares
|
— | 31 Dec 2025 |
| UBS Group AG |
13F
Company
|
1.8%
|
$8,978,679
1,411,742 shares
|
— | 31 Dec 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.6%
|
$8,237,043
1,294,863 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
141
Shares
36,661,503
Rows available
141
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
141
Q1 2026 holders
141
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend